- Home
- BOLT vs NEPH Comparison
BOLT vs NEPH Comparison
Compare BOLT & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- NEPH
- Stock Information
- Founded
- BOLT 2015
- NEPH 1997
- Country
- BOLT United States
- NEPH United States
- Employees
- BOLT N/A
- NEPH N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- NEPH Medical/Dental Instruments
- Sector
- BOLT Health Care
- NEPH Health Care
- Exchange
- BOLT Nasdaq
- NEPH Nasdaq
- Market Cap
- BOLT 16.8M
- NEPH 16.8M
- IPO Year
- BOLT 2021
- NEPH 2004
- Fundamental
- Price
- BOLT $0.40
- NEPH $2.13
- Analyst Decision
- BOLT Hold
- NEPH Buy
- Analyst Count
- BOLT 5
- NEPH 1
- Target Price
- BOLT $1.13
- NEPH $5.00
- AVG Volume (30 Days)
- BOLT 146.4K
- NEPH 12.4K
- Earning Date
- BOLT 05-13-2025
- NEPH 05-08-2025
- Dividend Yield
- BOLT N/A
- NEPH N/A
- EPS Growth
- BOLT N/A
- NEPH N/A
- EPS
- BOLT N/A
- NEPH 0.01
- Revenue
- BOLT $7,690,000.00
- NEPH $14,162,000.00
- Revenue This Year
- BOLT N/A
- NEPH $9.23
- Revenue Next Year
- BOLT $77.45
- NEPH $12.99
- P/E Ratio
- BOLT N/A
- NEPH $298.53
- Revenue Growth
- BOLT N/A
- NEPH N/A
- 52 Week Low
- BOLT $0.38
- NEPH $1.36
- 52 Week High
- BOLT $1.40
- NEPH $2.55
- Technical
- Relative Strength Index (RSI)
- BOLT 39.13
- NEPH 78.82
- Support Level
- BOLT $0.38
- NEPH $1.55
- Resistance Level
- BOLT $0.47
- NEPH $1.62
- Average True Range (ATR)
- BOLT 0.04
- NEPH 0.10
- MACD
- BOLT -0.00
- NEPH 0.06
- Stochastic Oscillator
- BOLT 13.27
- NEPH 87.79
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.